Search research articles
Contact Us
Filters
Showing results (381-390 of 471) with videos related to
Page
of 48
Sort By:
Journal of Crohn'S & Colitis
|
March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease
Axel Dignass, Neeraj Narula, Krishan Pratap, et al.
Inflammatory Bowel Diseases
|
April 4, 2025
Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program
Gary R Lichtenstein, Jessica R Allegretti, Edward V Loftus, et al.
Gastrointestinal Endoscopy
|
September 27, 2015
Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy
Parakkal Deepak, Gregory J Hanson, Joel G Fletcher, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 19, 2020
Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center
Lukasz Kwapisz, Laura E Raffals, David H Bruining, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 15, 2025
Long-Term Safety of Vedolizumab in Patients With Ulcerative Colitis/Crohn's Disease: A Prospective Observational Study
Edouard Louis, Shaji Sebastian, Britta Siegmund, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 2024
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study
Brian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 2020
Long-term safety of vedolizumab for inflammatory bowel disease
Edward V Loftus, Brian G Feagan, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
March 21, 2013
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study
Hans H Herfarth, Jeffry A Katz, Stephen B Hanauer, et al.
Inflammatory Bowel Diseases
|
November 9, 2020
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study
Guilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, et al.
Inflammatory Bowel Diseases
|
August 31, 2018
Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease
Badr Al-Bawardy, Guilherme Piovezani Ramos, Maria Alice V Willrich, et al.
Page
of 48
Search research articles
Search
Showing results (381-390 of 471) with videos related to
Sort By:
Page
of 48
Journal of Crohn'S & Colitis
|
March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease
Axel Dignass, Neeraj Narula, Krishan Pratap, et al.
Inflammatory Bowel Diseases
|
April 4, 2025
Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program
Gary R Lichtenstein, Jessica R Allegretti, Edward V Loftus, et al.
Gastrointestinal Endoscopy
|
September 27, 2015
Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy
Parakkal Deepak, Gregory J Hanson, Joel G Fletcher, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 19, 2020
Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center
Lukasz Kwapisz, Laura E Raffals, David H Bruining, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 15, 2025
Long-Term Safety of Vedolizumab in Patients With Ulcerative Colitis/Crohn's Disease: A Prospective Observational Study
Edouard Louis, Shaji Sebastian, Britta Siegmund, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 2024
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study
Brian G Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 2020
Long-term safety of vedolizumab for inflammatory bowel disease
Edward V Loftus, Brian G Feagan, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
March 21, 2013
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study
Hans H Herfarth, Jeffry A Katz, Stephen B Hanauer, et al.
Inflammatory Bowel Diseases
|
November 9, 2020
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study
Guilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, et al.
Inflammatory Bowel Diseases
|
August 31, 2018
Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease
Badr Al-Bawardy, Guilherme Piovezani Ramos, Maria Alice V Willrich, et al.
Page
of 48